Dermaticum - Prof. Dr. med. Rolf Hoffmann und Kollegen
- Address
- Kaiser-Joseph-Str. 262, 79098 Freiburg im Breisgau, Germany
Hormonal Diseases and Hair Loss Research
At Dermaticum - Prof. Dr. med. Rolf Hoffmann und Kollegen in Freiburg, clinical research focuses on hormonal diseases linked to androgenetic alopecia, with special attention to female androgenetic alopecia and related hair loss patterns. The studies are designed to assess whether new and existing treatments can improve hair growth and overall treatment benefit for people affected by hormone-related hair thinning.
- Evaluating treatment effectiveness for androgenetic alopecia
- Studying female androgenetic alopecia and hormone-related hair loss
- Testing whether new therapies can improve hair count and visible regrowth
The research at this site is centered on comparing active treatments with control approaches to better understand safety and benefit in everyday hair loss care.
Skin and Connective Tissue Diseases in Dermatology
This site also contributes to research in skin and connective tissue diseases, especially androgenetic alopecia as a dermatologic condition affecting both men and women. The trials aim to improve diagnosis and assess the effectiveness of therapies intended to support hair restoration and symptom management.
- Assessing oral minoxidil for hormone-imbalanced hair loss
- Studying clascoterone for male pattern hair loss
- Comparing active treatment with placebo or vehicle to clarify treatment value
With a small but focused trial portfolio, the practice is building evidence for better management of common hair loss conditions in clinical care.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Dermaticum - Prof. Dr. med. Rolf Hoffmann und Kollegen
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Clascoterone Solution Efficacy and Safety in Androgenetic Alopecia Treatment in Adult Males: A Phase 3 Randomized Double-Blind Study | Cassiopea S.p.A. | Phase III | Not Recruiting | Nov 2023 | Jul 2025 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Clascoterone | 1 | Unknown | 2023-11-21 | 2023-11-21 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.